Telomere length predicts neutrophil recovery in the absence of G-CSF after autologous peripheral blood stem cell transplantation

被引:0
|
作者
L F Lincz
F E Scorgie
J A Sakoff
K A Fagan
S P Ackland
A Enno
机构
[1] Hunter Haematology Research Group,Medical Oncology Department
[2] Mater Misericordiae Hospital,undefined
[3] Mater Misericordiae Hospital,undefined
[4] Cytogenetics Unit,undefined
[5] Hunter Area Pathology Service,undefined
[6] Hunter Haematology Unit,undefined
[7] Hunter Area Pathology Service,undefined
来源
Bone Marrow Transplantation | 2004年 / 34卷
关键词
telomere; haemopoietic recovery; G-CSF; autologous peripheral blood stem cell transplantation;
D O I
暂无
中图分类号
学科分类号
摘要
Haemopoietic regeneration after autologous peripheral blood progenitor cell (PBPC) transplantation can be delayed in some patients despite adequate infusion of CD34+ cells. This suggests variability in the proliferation potential of the implanted cells, a capacity that may be predicted by their telomere length. To test this theory, telomere length was measured on stored apheresis samples from 36 patients aged 46.6±11.1 years, who had undergone successful autologous PBPC transplantation with a median of 5.6 × 106/kg (1.3 × 106–36.1 × 106/kg) CD34+ cells. The mean PBPC telomere length for the cohort was 9.4±2.3 kbp. For patients who did not receive G-CSF post transplantation (n=7), days to absolute neutrophil recovery (ANC), ⩾0.1, 0.5 and 1.0 × 109 cells/l, were significantly inversely correlated with telomere length of the infused PBPC (r=−0.88, −0.81, −0.77, respectively; P<0.05,). However, no correlation was found for patients who received G-CSF from day 1 post transplantation (n=20). These data suggest that for transplantation with sufficient CD34+ cells, neutrophil recovery is less efficient in patients receiving infusions of cells with short telomeres, but this deficiency can be corrected with adequate post transplantation administration of G-CSF.
引用
收藏
页码:439 / 445
页数:6
相关论文
共 50 条
  • [21] G-CSF mobilized peripheral blood stem cell collection for allogeneic transplantation in healthy donors: Analysis of factors affecting yield
    Machaczka, Maciej
    Hagglund, Hans
    Staver, Emma
    Joks, Monika
    Hassan, Moustapha
    Wahlin, Bjorn Engelbrekt
    Nygell, Ulla Axdorph
    JOURNAL OF CLINICAL APHERESIS, 2017, 32 (06) : 384 - 391
  • [22] A randomized, multicenter study of G-CSF starting on day+1 vs day+5 after autologous peripheral blood progenitor cell transplantation
    de Azevedo, AM
    Nucci, M
    Maiolino, A
    Vigorito, AC
    Simoes, BP
    Aranha, FJP
    Tabak, DG
    Voltarelli, J
    de Souza, C
    BONE MARROW TRANSPLANTATION, 2002, 29 (09) : 745 - 751
  • [23] Autologous stem cell transplantation in chronic myeloid leukaemia using Philadelphia chromosome negative blood progenitors mobilised with hydroxyurea and G-CSF
    Pratt, G
    Johnson, RJ
    Rawstron, AC
    Barnard, DL
    Morgan, GJ
    Smith, GM
    BONE MARROW TRANSPLANTATION, 1998, 21 (05) : 455 - 460
  • [24] Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation
    Ravoet, C
    Feremans, W
    Husson, B
    Majois, F
    Kentos, A
    Lambermont, M
    Wallef, G
    Capel, P
    Beauduin, M
    Delannoy, A
    BONE MARROW TRANSPLANTATION, 1996, 18 (05) : 943 - 947
  • [25] Autologous stem cell transplantation in chronic myeloid leukaemia using Philadelphia chromosome negative blood progenitors mobilised with hydroxyurea and G-CSF
    G Pratt
    RJ Johnson
    AC Rawstron
    DL Barnard
    GJ Morgan
    GM Smith
    Bone Marrow Transplantation, 1998, 21 : 455 - 460
  • [26] Late autologous transplantation in chronic myelogenous leukemia with peripheral blood progenitor cells mobilized by G-CSF and interferon-α
    Michallet, M
    Thiébaut, A
    Philip, I
    Charrin, C
    Vigouroux, C
    Thomas, X
    Bilger, K
    Belhabri, A
    Guyotat, D
    Corront, B
    Salles, B
    Dumontet, C
    Peaud, PY
    Vilque, JP
    Devidas, A
    Fière, D
    LEUKEMIA, 2000, 14 (12) : 2064 - 2069
  • [27] Optimal timing of G-CSF administration for effective autologous stem cell collection
    Kim, J. E.
    Yoo, C.
    Kim, S.
    Lee, D. H.
    Kim, S-W
    Lee, J-S
    Suh, C.
    BONE MARROW TRANSPLANTATION, 2011, 46 (06) : 806 - 812
  • [28] Translating G-CSF as an Adjunct Therapy to Stem Cell Transplantation for Stroke
    dela Pena, Ike
    Borlongan, Cesar V.
    TRANSLATIONAL STROKE RESEARCH, 2015, 6 (06) : 421 - 429
  • [29] Translating G-CSF as an Adjunct Therapy to Stem Cell Transplantation for Stroke
    Ike dela Peña
    Cesar V. Borlongan
    Translational Stroke Research, 2015, 6 : 421 - 429
  • [30] Optimal timing of G-CSF administration for effective autologous stem cell collection
    J E Kim
    C Yoo
    S Kim
    D H Lee
    S-W Kim
    J-S Lee
    C Suh
    Bone Marrow Transplantation, 2011, 46 : 806 - 812